FLT3 and acute myeloid leukemia: Interestingly, FLT3-inhibitor resistance is attenuated by LCL-461, a mitochondria-targeted ceramide analog drug, which induces lethal mitophagy in human AML blasts with FLT3-ITD mutations [355].